M&A

M&A

ORG Financials / Investment Banking & Brokerage Momentum 12.6ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. NORMALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

M&A represents the mergers and acquisitions function and advisory ecosystem driving deal activity across healthcare, pharma, and industrials. Signal volume surged 19 headlines in 7 days covering biopharma strength despite large-deal slowdown, mid-market deal momentum, and expanding transaction regulation.

M&A activity spans pharma, healthcare systems, biopharma, and private equity across North America and Latin America. Recent signals highlight Bayer's return to pharma M&A, Sanford Health's healthcare consolidation deals, and mid-market deal acceleration. Regulatory scrutiny increasing via transaction review laws affecting healthcare sector consolidation.

-0.21

PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.

12.6

MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.

ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.

ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.

M&A is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

3.333

Narrative Drift

0.000

Spectral Shift

624.046

Sentiment-Momentum Divergence

0.000

Source Concentration

0.281

Signal

M&A is getting less coverage than expected — the market may be ignoring a developing story (primary driver: Attention Cascade).

Driver

Ranked #27 of 29 in — in line with sector peers. PSI stable vs yesterday (-1.00). Confidence: 63% (entity has limited history, score is shrunk toward sector prior).

Action

Baseline conditions. Continue standard monitoring cadence.

Peer Comparison

27 of 29

Sector Rank

+0.00

Peer Z-Score

Sector Percentile

Network Analysis

9 Degree Centrality

Ego Network (top connections)

Centrality History

Entity	Weight	Status
Alvarez	10	NEW
Brazil	10	NEW
Marsal	10	NEW
Mexico	5	NEW
Bloomberg	4	STABLE
Middle East	3	STABLE
CEO	3	STABLE
UnitedHealth Group	3	NEW
NEW YORK	2	STABLE
OpenAI	2	STABLE
Australia	2	NEW
Nigeria	2	STABLE
PwC	2	NEW
United Kingdom	2	STABLE
Eli Lilly	2	NEW
Japan	2	STABLE
Warren Buffett	2	NEW

Article Coverage (0)

Date	Lane	Title
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

M&A+ Note this entity

Request Access